Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,050 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease.
Noor NM, Sousa P, Bettenworth D, Gomollón F, Lobaton T, Bossuyt P, Casanova MJ, Ding NS, Dragoni G, Furfaro F, van Rheenen PF, Chaparro M, Gisbert JP, Louis E, Papamichail K. Noor NM, et al. Among authors: sousa p. J Crohns Colitis. 2023 Jul 5;17(7):1031-1045. doi: 10.1093/ecco-jcc/jjad001. J Crohns Colitis. 2023. PMID: 36626338 Free article.
Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
Magro F, Lopes S, Coelho R, Cotter J, Dias de Castro F, Tavares de Sousa H, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Chagas C, Torres J, Dias CC, Lopes J, Borralho P, Afonso J, Geboes K, Carneiro F; Portuguese IBD Study Group [GEDII]. Magro F, et al. Among authors: sousa a, sousa p. J Crohns Colitis. 2017 Apr 1;11(4):435-444. doi: 10.1093/ecco-jcc/jjw170. J Crohns Colitis. 2017. PMID: 27664275
The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients.
Magro F, Fernandes S, Patita M, Arroja B, Lago P, Rosa I, de Sousa HT, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Moreira P, Dias S, Afonso J, Danese S, Peyrin-Biroulet L, Vucicevic KM, Santiago M. Magro F, et al. Among authors: sousa p. J Crohns Colitis. 2024 Jan 19:jjae014. doi: 10.1093/ecco-jcc/jjae014. Online ahead of print. J Crohns Colitis. 2024. PMID: 38243908
Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
Magro F, Lopes J, Borralho P, Lopes S, Coelho R, Cotter J, Dias de Castro F, Tavares de Sousa H, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Chagas C, Cravo M, Dias CC, Afonso J, Portela F, Santiago M, Geboes K, Carneiro F. Magro F, et al. Among authors: sousa a, sousa p. J Crohns Colitis. 2020 Feb 10;14(2):169-175. doi: 10.1093/ecco-jcc/jjz123. J Crohns Colitis. 2020. PMID: 31504348
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.
Magro F, Estevinho MM, Catalano G, Patita M, Arroja B, Lago P, Rosa I, Tavares de Sousa H, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Moreira P, Santiago M, Dias S, Afonso J, Danese S, Peyrin-Biroulet L, Dias CC; GEDII (Grupo de Estudos da Doença Inflamatória Intestinal). Magro F, et al. Among authors: sousa p. United European Gastroenterol J. 2023 Jul;11(6):531-541. doi: 10.1002/ueg2.12420. Epub 2023 Jun 15. United European Gastroenterol J. 2023. PMID: 37318072 Free PMC article.
1,050 results